Comparison of neoadjuvant and adjuvant therapy for resectable pancreatic cancer using Markov decision modeling.

被引：0
|
作者：
Choi, Minsig
Ishizawa, Sayaka
Liang, Yan
Rashidian, Sina
Sasson, Aaron R.
Feinberg, Eugene
机构：
[1] SUNY Stony Brook, Stony Brook, NY 11794 USA
[2] Stony Brook Med, Stony Brook, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
448
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant and neoadjuvant therapy for resectable pancreatic cancer
    Ueno, Hideki
    Okusaka, Takuji
    Kosuge, Tomoo
    Motoi, Fuyuhiko
    Unno, Michiaki
    ANNALS OF ONCOLOGY, 2015, 26 : 9 - 9
  • [2] Adjuvant and Neoadjuvant Therapy for Resectable Pancreatic and Periampullary Cancer
    Kim, Stephanie M.
    Eads, Jennifer R.
    SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (06) : 1287 - +
  • [3] Adjuvant Therapy versus neoadjuvant Therapy for Borderline resectable Pancreatic Cancer
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (05): : 457 - 457
  • [4] Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?
    O'Reilly, Eileen M.
    Ferrone, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1757 - +
  • [5] Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis
    de Geus, S. W. L.
    Evans, D. B.
    Bliss, L. A.
    Eskander, M. F.
    Smith, J. K.
    Wolff, R. A.
    Miksad, R. A.
    Weinstein, M. C.
    Tseng, J. F.
    EJSO, 2016, 42 (10): : 1552 - 1560
  • [6] Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis
    Bradley, Alison
    Van der Meer, Robert
    PLOS ONE, 2019, 14 (02):
  • [7] Neoadjuvant and Adjuvant Therapy in Resectable Pancreatic Adenocarcinoma
    Johnson, Ryan
    McClelland, Paul H.
    Ahmad, Syed A.
    SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (05) : 987 - 1005
  • [8] Efficacy of Adjuvant Versus Neoadjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision Analysis
    Ito, Hiromichi
    Ruan, Daniel T.
    Whang, Edward E.
    GASTROENTEROLOGY, 2010, 138 (05) : S856 - S856
  • [9] Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision Analysis
    Sharma, Gaurav
    Whang, Edward E.
    Ruan, Daniel T.
    Ito, Hiromichi
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S1229 - S1237
  • [10] Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision Analysis
    Gaurav Sharma
    Edward E. Whang
    Daniel T. Ruan
    Hiromichi Ito
    Annals of Surgical Oncology, 2015, 22 : 1229 - 1237
12345